Stevanato Group SpA
Atvērts
SektorsVeselības aprūpe
16.98 -1.79
Pārskats
Akcijas cenas izmaiņa
24h
Min
16.6
Max
17.3
Ienākumi | -7.9M 39M |
|---|---|
Pārdošana | -70M 274M |
P/E Sektora vidējais | 28.186 49.712 |
EPS | 0.13 |
Peļņas marža | 14.343 |
Darbinieki | 6,010 |
EBITDA | -25M 65M |
Rekomendācijas | Pirkt (spēcīgs) |
|---|---|
Prognoze 12 mēnešiem | +29.7% upside |
Nākamie ieņēmumi | 2026. g. 4. aug. |
|---|
Tirgus kapitalizācija | -317M 4.5B |
|---|---|
Iepriekšējā atvēršanas cena | 18.77 |
Iepriekšējā slēgšanas cena | 16.98 |
Ziņu noskaņojums
By Acuity
13%
87%
16 / 342 Rangs Healthcare
Stevanato Group SpA Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
